These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
416 related articles for article (PubMed ID: 7683960)
1. Differential interactive effects of gliotoxin and MPTP in the substantia nigra and the locus coeruleus in BALB/c mice. Chang FW; Wang SD; Lu KT; Lee EH Brain Res Bull; 1993; 31(3-4):253-66. PubMed ID: 7683960 [TBL] [Abstract][Full Text] [Related]
2. Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the substantia nigra and the locus coeruleus in BALB/c mice. Hu SC; Chang FW; Sung YJ; Hsu WM; Lee EH J Pharmacol Exp Ther; 1991 Dec; 259(3):1379-87. PubMed ID: 1684822 [TBL] [Abstract][Full Text] [Related]
3. The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: role of BDNF gene expression. Hung HC; Lee EH Brain Res Mol Brain Res; 1996 Sep; 41(1-2):14-26. PubMed ID: 8883930 [TBL] [Abstract][Full Text] [Related]
4. Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusion. Chadi G; Møller A; Rosén L; Janson AM; Agnati LA; Goldstein M; Ogren SO; Pettersson RF; Fuxe K Exp Brain Res; 1993; 97(1):145-58. PubMed ID: 7907549 [TBL] [Abstract][Full Text] [Related]
6. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice. Aoki E; Yano R; Yokoyama H; Kato H; Araki T Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004 [TBL] [Abstract][Full Text] [Related]
7. Comparative studies of the neurotoxicity of MPTP in rats of different ages. Lee EH; Liu SP; Lu KT; Lin WR Chin J Physiol; 1992; 35(4):317-36. PubMed ID: 1364057 [TBL] [Abstract][Full Text] [Related]
8. Role of dopamine transporter against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in mice. Kurosaki R; Muramatsu Y; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T Metab Brain Dis; 2003 Jun; 18(2):139-46. PubMed ID: 12822832 [TBL] [Abstract][Full Text] [Related]
9. Systemic administration of proteasome inhibitor protects against MPTP neurotoxicity in mice. Oshikawa T; Kuroiwa H; Yano R; Yokoyama H; Kadoguchi N; Kato H; Araki T Cell Mol Neurobiol; 2009 Jul; 29(5):769-77. PubMed ID: 19370411 [TBL] [Abstract][Full Text] [Related]
10. Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine. Luellen BA; Miller DB; Chisnell AC; Murphy DL; O'Callaghan JP; Andrews AM J Pharmacol Exp Ther; 2003 Dec; 307(3):923-31. PubMed ID: 14561848 [TBL] [Abstract][Full Text] [Related]
11. Vagus nerve stimulation improves locomotion and neuronal populations in a model of Parkinson's disease. Farrand AQ; Helke KL; Gregory RA; Gooz M; Hinson VK; Boger HA Brain Stimul; 2017; 10(6):1045-1054. PubMed ID: 28918943 [TBL] [Abstract][Full Text] [Related]
12. Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment. Knyihár-Csillik E; Csillik B; Pákáski M; Krisztin-Péva B; Dobó E; Okuno E; Vécsei L Neuroscience; 2004; 126(4):899-914. PubMed ID: 15207325 [TBL] [Abstract][Full Text] [Related]
13. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway. Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626 [TBL] [Abstract][Full Text] [Related]
14. Role of nitric oxide synthase against MPTP neurotoxicity in mice. Kurosaki R; Muramatsu Y; Michimata M; Matsubara M; Kato H; Imai Y; Itoyama Y; Araki T Neurol Res; 2002 Oct; 24(7):655-62. PubMed ID: 12392201 [TBL] [Abstract][Full Text] [Related]
15. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice. Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T Glia; 2003 May; 42(3):307-13. PubMed ID: 12673835 [TBL] [Abstract][Full Text] [Related]
16. Differential effects of deprenyl and MPTP on catecholamines and activity in BALB/c mice. Chia LG; Liu SP; Lee EH Neuroreport; 1992 Sep; 3(9):777-80. PubMed ID: 1421136 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the effect of rotenone and 1‑methyl‑4‑phenyl‑1,2,3,6‑tetrahydropyridine on inducing chronic Parkinson's disease in mouse models. Zhang J; Sun B; Yang J; Chen Z; Li Z; Zhang N; Li H; Shen L Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35039876 [TBL] [Abstract][Full Text] [Related]
19. Plasticity of the nigrostriatal system in MPTP-treated mice. A biochemical and morphological correlation. Cruz-Sanchez FF; Cardozo A; Ambrosio S; Tolosa E; Mahy N Mol Chem Neuropathol; 1993; 19(1-2):163-76. PubMed ID: 8103334 [TBL] [Abstract][Full Text] [Related]
20. Evidence for a protective action of the vigilance promoting drug modafinil on the MPTP-induced degeneration of the nigrostriatal dopamine neurons in the black mouse: an immunocytochemical and biochemical analysis. Fuxe K; Janson AM; Rosén L; Finnman UB; Tanganelli S; Morari M; Goldstein M; Agnati LF Exp Brain Res; 1992; 88(1):117-30. PubMed ID: 1347270 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]